Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.

Next Previous
Trial Profile

Evaluation of anti oxidative effect of linagliptin on type 2 diabetic patients.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Linagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use

    • Most Recent Events

    • 30 Mar 2016 Status changed from recruiting to active, no longer recruiting.
    • 03 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top